Faltering weight and profound chronic anaemia lead today’s clinical learning
Stable observations do not make a haemoglobin around 30 g/L benign; chronic physiological compensation can conceal profound anaemia.
Profound microcytic anaemia provides one of today’s main acute-care problems. A haemoglobin around 30 g/L may coexist with relatively stable observations when blood loss has developed slowly, but physiological compensation does not make the result benign. The result should be repeated promptly, then interpreted alongside mean cell volume, iron studies, renal and liver tests and possible bleeding sites. Blood mixed with stoma output supports chronic gastrointestinal loss, while neglected dressings or stoma care may conceal further clinical risk. Red-cell transfusion should be cautious because a chronically anaemic patient may be relatively euvolaemic and vulnerable to fluid overload.
The same case reinforces that clinical assessment extends beyond laboratory values. Stomas, wounds and dressings need direct inspection when they may explain blood loss or deterioration. Capacity remains decision-specific and depends on understanding, retaining and weighing information and communicating a choice. Autism or ADHD should prompt clearer explanations, sensory adjustments, quieter surroundings and greater patient control over examination rather than assumptions about incapacity or non-engagement.
Faltering weight supplies the paediatric thread. Weight should be interpreted in proportion to length or BMI, with Z scores and change over time recorded rather than relying on a single centile. In a well child without vomiting, diarrhoea, respiratory symptoms, developmental concerns or other red flags, a detailed feeding history and calorie-focused intervention usually come before broad investigation. Formula preparation, effective breastfeeds, meal structure, grazing and sugar-sweetened drinks are high-yield areas to review. Severe growth deviation, an intake history that does not match observed growth or unreliable follow-up should lower the threshold for specialist or inpatient assessment.
Hypertension management adds practical prescribing decisions. Repeated accurate readings and home measurements can prevent treatment of white-coat hypertension. Low-dose combinations of first-line agents may reduce blood pressure more effectively and with fewer dose-related adverse effects than maximising a single medicine. Amlodipine-associated ankle swelling reflects increased capillary pressure from selective arteriolar dilatation rather than total-body fluid excess, so adding a diuretic does not address the mechanism. Renal function, sodium and potassium should be checked after starting or increasing renin–angiotensin system blockers or thiazide-type treatment.
The critical-care evidence cautions against reflex treatment of respiratory secretions. MARCH did not show a meaningful reduction in mechanical-ventilation duration from routine carbocisteine, nebulised hypertonic saline or their combination. Hypertonic saline may produce bronchoconstriction and transient hypoxaemia, so any use should have a clear indication and review point. Ventilator liberation remains centred on sedation review, spontaneous awakening and breathing trials, delirium prevention and early mobilisation, with local baseline practice considered before adopting tele-rehabilitation programmes.
The remaining episodes widen the diagnostic and professional perspective. Early post-take senior review can change an incorrect pathway, including recognition of a treatable stroke mimic, but dangerous causes still need active exclusion. Serious-illness conversations should begin before burdensome escalation becomes the default. Functional neurological disorder needs individualised goals and explanations, while children with achondroplasia require multidisciplinary surveillance and urgent reassessment when weakness, unsteadiness or raised intracranial-pressure symptoms suggest craniocervical complications.

Acute medicine clinicians and educators get a reflective clinical-reasoning discussion covering early senior review, stroke mimics, hemiplegic migraine and follow-up of apparently routine admissions. It also examines recognition of dying, serious-illness conversations, proportionate care and the value of specific positive feedback.

Primary-care, cardiology and acute medicine clinicians get a practical prescribing review of hypertension confirmation, first-line medication and low-dose combination therapy. Amlodipine-related oedema, ACE inhibitor cough or angioedema, thiazide-associated electrolyte disturbance, gout and medication intolerance are linked to mechanism-based troubleshooting and planned biochemical monitoring.

Critical-care and respiratory clinicians get an appraisal of mucoactive treatment for mechanically ventilated adults with difficult secretions. The neutral MARCH findings are considered alongside bronchoconstriction, transient hypoxaemia, ventilator liberation and selective rather than routine use, while tele-rehabilitation is linked to sedation reduction, breathing trials, mobilisation and post-ICU recovery.

Neurology clinicians and educators get a concise reminder that functional neurological disorder is clinically diverse. Assessment, explanation, treatment priorities and follow-up should be tailored to the individual rather than imposed through a single pathway, while growing research activity offers cautious grounds for optimism.
.jpg)
Paediatric, primary-care and gastroenterology clinicians get a structured approach to faltering weight. Weight-for-length or BMI Z scores, feeding history, stooling, development and red flags guide management, with calorie-focused intervention prioritised for well children and targeted investigation or specialist assessment reserved for severe, atypical or poorly responsive presentations.

Paediatric, orthopaedic and genetics teams get a focused review of FGFR3-related achondroplasia. Disproportionate short stature, proximal limb shortening and characteristic craniofacial features are connected to surveillance for foramen magnum stenosis, hydrocephalus, obstructive sleep apnoea, recurrent middle-ear disease and spinal complications.

Acute medicine, gastroenterology and haematology teams get a case involving profound microcytic anaemia, chronic gastrointestinal blood loss, blood in stoma output and self-neglect. It links cautious transfusion and investigation with direct examination of hidden care problems, decision-specific capacity, safeguarding and reasonable adjustments for neurodivergent patients.
When an extreme haemoglobin result is confirmed, interpret it with red-cell indices, fluid status and direct assessment of potential bleeding sites rather than relying on appearance alone. In a child with faltering weight, document proportional growth, feeding details and red flags before ordering broad tests. For ventilated patients with difficult secretions, define the intended benefit and review point before starting a mucoactive medicine.
An adult has haemoglobin 30 g/L, an MCV of 63 fL, stable observations and blood mixed with stoma output. What process is most likely, and how should transfusion be approached?
The pattern supports severe microcytic anaemia from chronic gastrointestinal blood loss. Red cells should be given cautiously with fluid-status and clinical-response monitoring while the bleeding source and iron deficiency are investigated.
A well 4-month-old has crossed two centile lines and has a weight-for-length Z score of −1.8, with no vomiting, diarrhoea, respiratory symptoms or developmental concerns. What is the appropriate initial approach?
Diagnose faltering weight, take a detailed feeding history and begin a calorie-focused intervention with early growth review. Broad investigation is usually reserved for red flags, severe malnutrition, an inconsistent history or poor response.
An intubated adult has thick secretions requiring frequent suction. What do the MARCH findings imply about routine carbocisteine or nebulised hypertonic saline?
Routine treatment does not meaningfully shorten mechanical ventilation. Mucoactives should be used selectively with a defined review point, and hypertonic saline should be stopped or reconsidered if bronchoconstriction or hypoxaemia occurs.